Penghsuan Huang

Mr. Penghsuan Huang

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHua Zhang
Hua Zhang
YLYuan Liu
Yuan Liu
LFLauren Fields
Lauren Fields
XSXudong Shi
Xudong Shi
PHPenghsuan Huang
Penghsuan Huang
LLLingjun Li
Lingjun Li
Single-cell (SC) analysis provides unique insight into individual cell dynamics and cell-to-cell heterogeneity. Here, we utilize trapped ion mobility separation coupled with dual-polarity ionization mass spectrometry imaging (MSI) to enable high-throughput in situ profiling of the SC lipidome. Multimodal SC imaging, in which dual-polarity-mode MSI is used to perform serial data acquisition runs on individual cells, significantly enhanced SC lipidome coverage. High-spatial resolution SC-MSI identifies both inter- and intracellular lipid heterogeneity; this heterogeneity is further explicated by Uniform Manifold Approximation and Projection and machine learning-driven classifications. We characterize SC lipidome alteration in response to stearoyl-CoA desaturase 1 inhibition and, additionally, identify cell-layer specific lipid distribution patterns in mouse cerebellar cortex. This integrated multimodal SC-MSI technology enables high-resolution spatial mapping of intercellular and cell-to-cell lipidome heterogeneity, SC lipidome remodeling induced by pharmacological intervention, and region-specific lipid diversity within tissue.

8 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYaxian Zhou
Yaxian Zhou
CLChunrong Li
Chunrong Li
XCXuankun Chen
Xuankun Chen
YZYuan Zhao
Yuan Zhao
YLYaxian Liao
Yaxian Liao
WTWeiping Tang
Weiping Tang
Targeted protein degradation has emerged as a novel therapeutic modality to treat human diseases by utilizing the cell’s own disposal systems to remove protein target. Significant clinical benefits have been observed for degrading many intracellular proteins. Recently, the degradation of extracellular proteins in the lysosome has been developed. However, there have been limited successes in selectively degrading protein targets in disease-relevant cells or tissues, which would greatly enhance the development of precision medicine. Additionally, most degraders are not readily available due to their complexity. We report a class of easily accessible Folate Receptor TArgeting Chimeras (FRTACs) to recruit the folate receptor, primarily expressed on malignant cells, to degrade extracellular soluble and membrane cancer-related proteins in vitro and in vivo. Our results indicate that FRTAC is a general platform for developing more precise and effective chemical probes and therapeutics for the study and treatment of cancers.

22 April 2025 in Nature Methods
Verified
Journal Article
Open access
PDF file
HZHua Zhang
Hua Zhang
LDLang Ding
Lang Ding
AHAmy Hu
Amy Hu
XSXudong Shi
Xudong Shi
PHPenghsuan Huang
Penghsuan Huang
LLLingjun Li
Lingjun Li
The spatial distribution of diverse biomolecules in multicellular organisms is essential for their physiological functions. High-throughput in situ mapping of biomolecules is crucial for both basic and medical research, and requires high scanning speed, spatial resolution, and chemical sensitivity. Here we developed a tissue-expansion method compatible with matrix-assisted laser desorption/ionization mass-spectrometry imaging (TEMI). TEMI reaches single-cell spatial resolution without sacrificing voxel throughput and enables the profiling of hundreds of biomolecules, including lipids, metabolites, peptides (proteins), and N-glycans. Using TEMI, we mapped the spatial distribution of biomolecules across various mammalian tissues and uncovered metabolic heterogeneity in tumors. TEMI can be easily adapted and broadly applied in biological and medical research, to advance spatial multi-omics profiling.

13 August 2025 in Proteomics
Verified
Journal Article
Open access
GLGaoyuan Lu
Gaoyuan Lu
SXShuling Xu
Shuling Xu
PHPenghsuan Huang
Penghsuan Huang
LLLingjun Li
Lingjun Li
Lipids, indispensable yet structurally intricate biomolecules, serve as critical regulators of cellular function and disease progression. Conventional lipidomics, constrained by limited resolution for isomeric and low‐abundance species, has been transformed by ion mobility‐mass spectrometry (IM‐MS). This technology augments analytical power through enhanced orthogonal separation, collision cross‐section (CCS)‐based identification, and improved sensitivity. This review examines the transformative advances in IM‐MS‐driven lipidomics, focusing on three major pillars: (1) a critical evaluation of leading ion mobility spectrometry (IMS) platforms, emphasizing innovative instrument geometries and breakthroughs in resolving lipid isomers; (2) an exploration of lipid CCS databases and predictive frameworks, spotlighting computational modeling and machine learning strategies that synergize experimental data with molecular representations for high‐confidence lipid annotation; (3) emerging multi‐dimensional lipidomics workflows integrating CCS with liquid chromatography‐MS/MS to boost identification and depth, alongside mass spectrometry imaging for spatially resolved lipidomics. By unifying cutting‐edge instrumentation, computational advances, and biological insights, this review outlines a roadmap for leveraging IM‐MS to unravel lipidome complexity, catalyzing biomarker discovery and precision medicine innovation.

16 July 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ZZZhen Zhang
Zhen Zhang
CLChunrong Li
Chunrong Li
NHNina J. Hawkins
Nina J. Hawkins
RMRamesh Mudududdla
Ramesh Mudududdla
YNYiming Nie
Yiming Nie
WTWeiping Tang
Weiping Tang
Receptor-interacting protein kinase 1 (RIPK1) is a threonine/serine kinase that serves as a critical regulator of immune responses and cell death pathways, functioning through both its kinase activity and nonenzymatic scaffolding function. The scaffolding function of RIPK1 contributes to both intrinsic and extrinsic resistance to immune checkpoint blockades (ICBs), making it a compelling therapeutic target for cancer treatment. Recent studies have highlighted RIPK1's potential as a key modulator for improving the efficacy of immune-stimulatory therapies, such as ICBs and X-ray radiotherapy (XRT). In this study, we have developed a highly potent and selective RIPK1 degrader. When combined with XRT, the degrader significantly suppressed tumor growth, achieving enhanced therapeutic efficacy without apparent adverse effects. In contrast, the RIPK1 inhibitor showed no notable therapeutic effect. These findings underscore the potential of targeting RIPK1 degradation, specifically its nonenzymatic function, as a novel strategy to augment the effects of radiotherapy.

27 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HZHua Zhang
Hua Zhang
LDLang Ding
Lang Ding
AHAmy Hu
Amy Hu
XSXudong Shi
Xudong Shi
PHPenghsuan Huang
Penghsuan Huang
LLLingjun Li
Lingjun Li
The spatial distribution of diverse biomolecules in multicellular organisms is essential for their physiological functions. High-throughput in situ mapping of biomolecules is crucial for both basic and medical research, and requires high scanning speed, spatial resolution, and chemical sensitivity. Here, we developed a Tissue Expansion method compatible with matrix-assisted laser desorption/ionization Mass spectrometry Imaging (TEMI). TEMI reaches single-cell spatial resolution without sacrificing voxel throughput and enables the profiling of hundreds of biomolecules, including lipids, metabolites, peptides (proteins), and N-glycans. Using TEMI, we mapped the spatial distribution of biomolecules across various mammalian tissues and uncovered metabolic heterogeneity in tumors. TEMI can be easily adapted and broadly applied in biological and medical research, to advance spatial multi-omics profiling.